Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malini Basu

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Cells|January 5, 2021
Tumor Suppressors Having Oncogenic Functions: The Double AgentsNeerajana Datta, Shrabastee Chakraborty, Malini Basu, et al.
Signal Transduction and Targeted Therapy|July 4, 2018
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseasesSeemana Bhattacharya, Dipankar Chakraborty, Malini Basu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|February 15, 2023
USP7 imparts partial EMT state in colorectal cancer by stabilizing the RNA helicase DDX3X and augmenting Wnt/β-catenin signalingBhaskar Basu, Subhajit Karmakar, Malini Basu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 24, 2025
CHIP modulates Wnt/β-catenin signalling in colorectal cancer through proteasomal degradation of DDX17Sunny Kumar, Sayani Ghosh, Malini Basu, et al.
European Journal of Pharmacology|February 14, 2025
CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapySubhajit Karmakar, Mouli Chatterjee, Malini Basu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 19, 2024
MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectivesRajni Shaw, Malini Basu, Subhajit Karmakar, et al.
Signal Transduction and Targeted Therapy|October 23, 2019
The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reportsMrinal K Ghosh, Dipankar Chakraborty, Sibani Sarkar, et al.
Life Sciences|August 30, 2024
GBM immunotherapy: Exploring molecular and clinical frontiersMrinal K Ghosh, Sunny Kumar, Sabana Begam, et al.
International Journal of Pharmaceutics|September 13, 2024
Glioma nanotherapy: Unleashing the synergy of dual-loaded DIM and TMZSibani Sarkar, Sunny Kumar, Gouranga Saha, et al.
Journal of Cell Science|September 7, 2023
The E3 ubiquitin ligase CHIP drives monoubiquitylation-mediated nuclear import of the tumor suppressor PTENShrabastee Chakraborty, Subhajit Karmakar, Malini Basu, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cells|January 5, 2021
Tumor Suppressors Having Oncogenic Functions: The Double AgentsNeerajana Datta, Shrabastee Chakraborty, Malini Basu, et al.
Signal Transduction and Targeted Therapy|July 4, 2018
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseasesSeemana Bhattacharya, Dipankar Chakraborty, Malini Basu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|February 15, 2023
USP7 imparts partial EMT state in colorectal cancer by stabilizing the RNA helicase DDX3X and augmenting Wnt/β-catenin signalingBhaskar Basu, Subhajit Karmakar, Malini Basu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 24, 2025
CHIP modulates Wnt/β-catenin signalling in colorectal cancer through proteasomal degradation of DDX17Sunny Kumar, Sayani Ghosh, Malini Basu, et al.
European Journal of Pharmacology|February 14, 2025
CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapySubhajit Karmakar, Mouli Chatterjee, Malini Basu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 19, 2024
MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectivesRajni Shaw, Malini Basu, Subhajit Karmakar, et al.
Signal Transduction and Targeted Therapy|October 23, 2019
The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reportsMrinal K Ghosh, Dipankar Chakraborty, Sibani Sarkar, et al.
Life Sciences|August 30, 2024
GBM immunotherapy: Exploring molecular and clinical frontiersMrinal K Ghosh, Sunny Kumar, Sabana Begam, et al.
International Journal of Pharmaceutics|September 13, 2024
Glioma nanotherapy: Unleashing the synergy of dual-loaded DIM and TMZSibani Sarkar, Sunny Kumar, Gouranga Saha, et al.
Journal of Cell Science|September 7, 2023
The E3 ubiquitin ligase CHIP drives monoubiquitylation-mediated nuclear import of the tumor suppressor PTENShrabastee Chakraborty, Subhajit Karmakar, Malini Basu, et al.
Pageof 3